NON-SMALL LUNG CANCER
Clinical trials for NON-SMALL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL LUNG CANCER trials appear
Sign up with your email to follow new studies for NON-SMALL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for lung cancer patients when First-Line drug fails
Disease control Not yet recruitingThis study aims to gather real-world information on how well the drug taletrectinib works and how safe it is for people with advanced ROS1-positive non-small cell lung cancer. It focuses on patients whose cancer has continued to grow despite treatment with another targeted drug c…
Matched conditions: NON-SMALL LUNG CANCER
Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New targeted therapy trial offers hope for Tough-to-Treat lung cancer
Disease control Not yet recruitingThis study is testing an experimental drug called SKB571 for people with advanced non-small cell lung cancer that has a specific genetic change called a MET abnormality. The trial will enroll 60 patients whose cancer has worsened after standard treatments to see if the drug is sa…
Matched conditions: NON-SMALL LUNG CANCER
Phase: PHASE2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC